CCAP — Crescent Capital Bdc Income Statement
0.000.00%
Last trade - 00:00
- $680.45m
- $1.55bn
- $184.13m
- 70
- 90
- 83
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 53.5 | 77.1 | 94 | 117 | 184 |
Cost of Revenue | |||||
Gross Profit | 34.5 | 53.4 | 53 | 56.7 | 87.2 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21.7 | 30.5 | 44.1 | 56.8 | 100 |
Operating Profit | 31.8 | 46.6 | 49.9 | 59.9 | 83.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 29.4 | 55.2 | 85.9 | 15.7 | 85.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 29.3 | 54.7 | 83.6 | 15.5 | 83.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 29.3 | 54.7 | 83.6 | 15.5 | 83.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.3 | 54.7 | 83.6 | 15.5 | 83.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.4 | 2.11 | 2.94 | 0.503 | 2.33 |
Dividends per Share | |||||
Special Dividends per Share |